L‐asparaginase treatment in acute lymphoblastic leukemia: A focus on Erwinia asparaginase

Cited by (564)

Items 101–200 of 564

  1. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia
    Roel Polak, Marc Bierings, Cindy S. van der Leije, Mathijs Arnoud Sanders, Onno Roovers, João R.M. Marchante, Judith M. Boer, Jan J. Cornelissen, Rob Pieters, Monique L. den Boer et al. · 2018 · Haematologica
  2. Asparaginase in the treatment of non-ALL hematologic malignancies
    Ashkan Emadi, Hania Zokaee, Edward A. Sausville · 2014 · Cancer Chemotherapy and Pharmacology
  3. 15 years of ATTEMPTS: A macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting
    Junxiao Ye, Meong Cheol Shin, Qiuling Liang, Huining He, Victor Chi-Min Yang · 2014 · Journal of Controlled Release
  4. The why and how of amino acid analytics in cancer diagnostics and therapy
    Friederike Manig, Konstantin Kuhne, Cläre von Neubeck, Uwe Schwarzenbolz, Zhanru Yu, Benedikt Mathias Kessler, Jens Pietzsch, Leoni A. Kunz‐Schughart · 2016 · Journal of Biotechnology
  5. Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker
    Robin Q.H. Kloos, Inge Margriet van der Sluis, Enrico Mastrobattista, Wim E. Hennink, Rob Pieters, Jan‐Jaap Verhoef · 2019 · British Journal of Haematology
  6. Cloning, expression and characterization of the recombinant Yersinia pseudotuberculosis l-asparaginase
    M. V. Pokrovskaya, С. С. Александрова, Vadim S. Pokrovsky, N M Omel'ianiuk, Anna A. Borisova, N. Yu. Anisimova, Nikolay N. Sokolov · 2011 · Protein Expression and Purification
  7. Hyperammonemia secondary to asparaginase: A case series
    Vicki M. Nussbaum, Nicole Lubcke, Russell Findlay · 2014 · Journal of Oncology Pharmacy Practice
  8. Red Blood Cell-Encapsulated L-Asparaginase: Potential Therapy of Patients with Asparagine Synthetase Deficient Acute Myeloid Leukemia
    Vaidehi Agrawal, Jung Hee Woo, Gautham Borthakur, Hagop M. Kantarjian, Arthur Edward Frankel · 2013 · Protein and Peptide Letters
  9. Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia
    Michael James Burke, Susan R. Rheingold · 2016 · Leukemia & lymphoma/Leukemia and lymphoma
  10. Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
    Rui Ni, Ziwei Li, Li Li, Dan Peng, Yue Ming, Lin Li, Yao Liu · 2023 · Frontiers in Oncology
  11. Screening and Isolation of Novel Glutaminase Free L-asparaginase from Fungal Endophytes
    Sathyanarayana Naidu Gummadi, A. Nagarajan, N. Thirunavuk, T.S. Suryanaray · 2014 · Research Journal of Microbiology
  12. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
    Shih‐Hsiang Chen · 2014 · Pediatrics & Neonatology
  13. Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
    Alaeddin Khalil, Gudrun Würthwein, Jana Golitsch, Georg Hempel, Manfred Fobker, Joachim Gerß, Anja Möricke, Martin Zimmermann, Petr Smíšek, Massimo Zucchetti et al. · 2020 · Haematologica
  14. Tumor microbiome: roles in tumor initiation, progression, and therapy
    Shengxin Zhang, Jing Huang, Zedong Jiang, Huan Tong, Xuelei Ma, Yang Liu · 2025 · Molecular Biomedicine
  15. Acute Lymphoblastic Leukemia in Children
    J. Roganović · 2013 · Journal of Indian Academy of Oral Medicine and Radiology
  16. Not All Wnt Activation Is Equal: Ligand-Dependent versus Ligand-Independent Wnt Activation in Colorectal Cancer
    Sam O. Kleeman, Simon John Leedham · 2020 · Cancers
  17. Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia
    Krzysztof Jędraszek, Marta Malczewska, Karolina Parysek-Wójcik, Monika Lejman · 2022 · International Journal of Molecular Sciences
  18. Improvement of stability and enzymatic activity by site-directed mutagenesis of E. coli asparaginase II
    Shikha Verma, Ranjit Kumar Mehta, Prasanta Kumar Maiti, Klaus‐Heinrich Röhm, Avinash Sonawane · 2014 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  19. Human 60-kDa Lysophospholipase Contains an N-terminal l-Asparaginase Domain That Is Allosterically Regulated by l-Asparagine
    Christos S. Karamitros, Manfred Konrad · 2014 · Journal of Biological Chemistry
  20. Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy
    Wing H. Tong, Inge Margriet van der Sluis, C Alleman, Raphaële R. L. van Litsenburg, Gertjan J.L. Kaspers, Rob Pieters, Carin A. Uyl‐de Groot · 2013 · Haematologica
  21. Exceptional thermal stability of therapeutical enzymes entrapped in alumina sol–gel matrices
    Vladimir V. Vinogradov, David Avnir · 2014 · Journal of Materials Chemistry B
  22. Low Bioavailability and High Immunogenicity of a New Brand of E. coli l-Asparaginase with Active Host Contaminating Proteins
    Priscila Pini Zenatti, Natacha Azussa Migita, Nathália Moreno Cury, Rosângela Aparecida Mendes-Silva, Fabio Cesar Gozzo, Pedro Otavio de Campos-Lima, José Andrés Yunes, Sílvia Regina Brandalise · 2018 · EBioMedicine
  23. Simultaneous cell disruption and semi-quantitative activity assays for high-throughput screening of thermostable L-asparaginases
    Xu Li, Xian Zhang, Shuqin Xu, Hengwei Zhang, Meijuan Xu, Taowei Yang, Li Wang, Haifeng Qian, Huiling Zhang, Haitian Fang et al. · 2018 · Scientific Reports
  24. Allergic‐like reactions to asparaginase: Atypical allergies without asparaginase inactivation
    Robin Q.H. Kloos, Rob Pieters, Gabriele Escherich, Inge Margriet van der Sluis · 2016 · Pediatric Blood & Cancer
  25. Microbial production, molecular modification, and practical application of l-Asparaginase: A review
    Yiming Wang, Wei Xu, Hao Wu, Wenli Zhang, Cuie Guang, Wanmeng Mu · 2021 · International Journal of Biological Macromolecules
  26. Targeting amino acid metabolism in cancer
    Lucie Safrhansova, Kateřina Hložková, Júlia Starková · 2022 · International review of cytology
  27. A sulfoximine-based inhibitor of human asparagine synthetase kills l-asparaginase-resistant leukemia cells
    Hideyuki Ikeuchi, Yong‐Mo Ahn, Takuya Otokawa, Bunta Watanabe, Lamees Hegazy, Jun Hiratake, Nigel G. J. Richards · 2012 · Bioorganic & Medicinal Chemistry
  28. L-Asparaginase from Microbes: a Comprehensive Review
    Devarai Santhosh Kumar, Kota Sobha · 2012
  29. Comparison of hypersensitivity rates to intravenous and intramuscular PEG‐asparaginase in children with acute lymphoblastic leukemia: A meta‐analysis and systematic review
    Haroon Hasan, Omar Mohammad Shaikh, Shahrad Rod Rassekh, A. Fuchsia Howard, Karen Goddard · 2016 · Pediatric Blood & Cancer
  30. Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review
    Cynthia Bender, Luke Devon Maese, Maria Carter‐Febres, Anupam R. Verma · 2021 · Blood and Lymphatic Cancer Targets and Therapy
  31. Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia
    Dan Douer, Nicola Gökbuget, Wendy Stock, Nicolas Boissel · 2021 · Blood Reviews
  32. HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway
    Jung Kwon Lee, SungMyung Kang, Xidi Wang, Jesusa L. Rosales, Xu Gao, Hee‐Guk Byun, Yan Jin, Songbin Fu, Jinghua Wang, Ki‐Young Lee · 2019 · Blood
  33. Clinical application of asparaginase activity levels following treatment with pegaspargase
    Archie Bleyer, Barbara L. Asselin, Susannah E. Koontz, Stephen P. Hunger · 2014 · Pediatric Blood & Cancer
  34. Partial purification and characterization of L-asparaginase from an endophytic Talaromyces pinophilus isolated from the rhizomes of Curcuma amada
    Prajna Rao Krishnapura, Prasanna Devarbhat Belur · 2015 · Journal of Molecular Catalysis B Enzymatic
  35. Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation-induced T cell metabolic reprogramming
    AnnMarie Torres, Joanna D Luke, Amy L. Kullas, Kanishk Kapilashrami, Yair M. Botbol, Antonius A. Koller, Peter J. Tonge, Emily I. Chen, Fernando Macián, Adrianus W. M. van der Velden · 2015 · Journal of Leukocyte Biology
  36. De Novo Engineering of a Human Cystathionine-γ-Lyase for Systemic l -Methionine Depletion Cancer Therapy
    Everett M Stone, Olga Paley, Jian Hu, Barbara L. Ekerdt, Nai‐Kong V. Cheung, George Georgiou · 2012 · ACS Chemical Biology
  37. HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
    Nóra Kutszegi, Xiaoqing Yang, András Gézsi, Géza Schermann, Daniel Janos Erdelyi, Ágnes F. Semsei, Krisztina Míta Gábor, Judit C. Sági, Gábor Kovács, András Falus et al. · 2017 · Haematologica
  38. Metabolic reprogramming of the tumor microenvironment by p62 and its partners
    Miguel Reina‐Campos, Phillip M. Shelton, Maria Teresa Díaz-Meco, Jorge Moscat · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  39. Erythrocyte Encapsulated L -Asparaginase (Graspa) in Acute Leukemia
    Xavier Thomas, Caroline Le Jeune · 2016 · International Journal of Hematologic Oncology
  40. Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
    Carmelo Rizzari, Claudia Lanvers‐Kaminsky, Maria Grazia Valsecchi, Andrea Ballerini, Cristina Matteo, Joachim Gerß, Gudrun Würthwein, Daniela Silvestri, Antonella Colombini, Valentino Conter et al. · 2019 · Haematologica
  41. Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
    Van Huynh, Sharon Bergeron · 2017 · Clinical journal of oncology nursing
  42. Genetic predisposition to PEG ‐asparaginase hypersensitivity in children treated according to NOPHO ALL 2008
    Sofie Gottschalk Højfeldt, Benjamin Ole Wolthers, Morten Tulstrup, Jonas Abrahamsson, Ramneek Gupta, Arja H. Harila‐Saari, Mats Marshall Heyman, Louise Tram Henriksen, Ólafur G. Jónsson, Päivi M. Lähteenmäki et al. · 2018 · British Journal of Haematology
  43. Construction of Enzyme Nanoreactors to Enable Tumor Microenvironment Modulation and Enhanced Cancer Treatment
    Xiaowen Liu, Yu Hao, Rachela Popovtzer, Liangzhu Feng, Zhuang Liu · 2020 · Advanced Healthcare Materials
  44. Extracellular Production of Recombinant l-Asparaginase II in Escherichia coli: Medium Optimization Using Response Surface Methodology
    Mohammad Bagher Ghoshoon, Aydin Berenjian, Shiva Hemmati, Fatemeh Dabbagh, Zeinab Karimi, Manica Negahdaripour, Younes Ghasemi · 2015 · International Journal of Peptide Research and Therapeutics
  45. Molecular and Spectroscopic Characterization of Aspergillus flavipes and Pseudomonas putida L-Methionine γ-Lyase in Vitro
    Ashraf S. A. El‐Sayed, Laura E. Ruff, Salah E. Abdel‐Ghany, Gul Shad Ali, Sadik Esener · 2016 · Applied Biochemistry and Biotechnology
  46. L-asparaginase produced from soil isolates of Pseudomonas aeruginosa shows potent anti-cancer activity on HeLa cells
    Nuzhath Fatima, Mohd. Mazharuddin Khan, Imran Ali Khan · 2019 · Saudi Journal of Biological Sciences
  47. Amino Acid Degrading Enzymes and Autophagy in Cancer Therapy
    Ziyu Wang, Qinghong Xie, Haifeng Zhou, Min Zhang, Jie Shen, Dianwen Ju · 2021 · Frontiers in Pharmacology
  48. Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers
    Gaurav Pathria, Ze’ev A. Ronai · 2021 · Cell Metabolism
  49. Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?
    Luke Devon Maese, Carmelo Rizzari, Russell Coleman, Austin Power, Inge Margriet van der Sluis, Rachel E. Rau · 2021 · Pediatric Blood & Cancer
  50. Haemostatic alterations induced by treatment with asparaginases and clinical consequences
    Tommaso Zà, Angela Ciminello, Silvia Betti, Elena Giulia Rossi, Valerio De Stefano · 2014 · Thrombosis and Haemostasis
  51. Prolonged first‐line PEG‐asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol—Pharmacokinetics and antibody formation
    Louise Tram Henriksen, Sofie Gottschalk Højfeldt, Kjeld Schmiegelow, Thomas Leth Frandsen, Peder Skov Wehner, Henrik Daa Schrøder, Birgitte Klug Albertsen, on behalf of the Nordic Society of Pediatric Hematology and Oncology, NOPHO Group · 2017 · Pediatric Blood & Cancer
  52. Managing Hypersensitivity to Asparaginase in Pediatrics, Adolescents, and Young Adults
    Sara Shinnick, Mary Browning, Susannah E. Koontz · 2013 · Journal of Pediatric Oncology Nursing
  53. A comparison of asparaginase activity in generic formulations of E.coli derived L‐ asparaginase: In‐vitro study and retrospective analysis of asparaginase monitoring in pediatric patients with leukemia
    Hari Sankaran, Soumika Sengupta, Vaitashi Purohit, Anand Kotagere, Nirmalya Roy Moulik, Maya Prasad, Chetan Anil Dhamne, Gaurav Narula, Shripad Dinanath Banavali, Vikram S. Gota · 2020 · British Journal of Clinical Pharmacology
  54. Insights into Asparaginase from Endophytic Fungus Lasiodiplodia theobromae: Purification, Characterization and Antileukemic Activity
    Hani Moubasher, Bassem A. Balbool, Yosra A. Helmy, Amnah Mohammed Alsuhaibani, Ahmed A. Atta, Donia H. Sheir, Ahmed M. Abdel-Azeem · 2022 · International Journal of Environmental Research and Public Health
  55. Synthesis and characterization of biodegradable pHEMA-starch composites for immobilization of L-asparaginase
    Ahmet Ulu, Süleyman Köytepe, Burhan Ateş · 2015 · Polymer Bulletin
  56. l-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review
    María Tosta Pérez, Lisandra Herrera Belén, Pablo J. Letelier, Yolanda Calle, Adalberto Pessoa, Jorge G. Farías · 2023 · Medical Oncology
  57. PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
    Camile Valle Medawar, Gabriela Bittencourt González Mosegui, Cid Manso de Mello Vianna, Talita Martins Alves da Costa · 2019 · Hematology Transfusion and Cell Therapy
  58. Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia
    Ruizhi Zhou, Tianqi Liang, Tianwen Li, Junbin Huang, Chun Chen · 2023 · Frontiers in Oncology
  59. Purification and Biochemical Characterization of Native and Pegylated Form of L-Asparaginase from Aspergillus terreus and Evaluation of Its Antiproliferative Activity
    Cláudio Battiston Loureiro, Kleiton Silva Borges, Augusto Faria Andrade, Luíz Gonzaga Tone, Suraia Said · 2012 · Advances in Microbiology
  60. Nanotechnology in Enzyme Immobilization: An Overview on Enzyme Immobilization with Nanoparticle Matrix
    Kushagri Singh, Abha Mishra, Deepankar Sharma, Kavita Singh · 2018 · Current Nanoscience
  61. Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion
    André Baruchel, Patrick Andrew Brown, Carmelo Rizzari, Lewis B. Silverman, Inge Margriet van der Sluis, Benjamin Ole Wolthers, Kjeld Schmiegelow · 2020 · ESMO Open
  62. Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study
    Luke Devon Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Robert Iannone, Jeffrey Alan Silverman, Lewis B. Silverman et al. · 2022 · Blood
  63. Clinical updates in adult acute lymphoblastic leukemia
    Omar Al Ustwani, Neha Gupta, Hatoon Bakhribah, Elizabeth A. Griffiths, Eunice S. Wang, Meir Wetzler · 2015 · Critical Reviews in Oncology/Hematology
  64. Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII
    Sanjay Rathod, Manda J. Ramsey, Mary V. Relling, Fred D. Finkelman, Christian Antonio Fernandez · 2018 · Haematologica
  65. Insight into the thermostability of thermophilic L-asparaginase and non-thermophilic L-asparaginase II through bioinformatics and structural analysis
    Xu Li, Xian Zhang, Shuqin Xu, Meijuan Xu, Taowei Yang, Li Wang, Huiling Zhang, Haitian Fang, Tolbert Osire, Zhiming Rao · 2019 · Applied Microbiology and Biotechnology
  66. Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells
    Cedric Stevens Tremblay, Sung Kai Chiu, Jesslyn Saw, Hannah McCalmont, Véronique Litalien, Jacqueline Anne Boyle, Stefan Sonderegger, Ngoc Chau, Kathryn Evans, Loretta Cerruti et al. · 2020 · Nature Communications
  67. Bioprocess Optimization of Nutritional Parameters for Enhanced Anti-leukemic L-Asparaginase Production by Aspergillus candidus UCCM 00117: A Sequential Statistical Approach
    Maurice Ekpenyong, Atim Asitok, Richard Antigha, Nkpa Mba Ogarekpe, Ubong Ekong, Marcus Inyama Asuquo, Joseph P. Essien, S. P. Antai · 2021 · International Journal of Peptide Research and Therapeutics
  68. SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia
    Kjeld Schmiegelow, Cecilie Utke Rank, Wendy Stock, Emily Dworkin, Inge Margriet van der Sluis · 2021 · Clinical Lymphoma Myeloma & Leukemia
  69. Recombinant Deamidated Mutants of Erwinia chrysanthemi l-Asparaginase Have Similar or Increased Activity Compared to Wild-Type Enzyme
    David P. Gervais, Nicholas Foote · 2014 · Molecular Biotechnology
  70. Do immunoglobulin G and immunoglobulin E anti- l -asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional study
    Gabriela Galindo Rodríguez, José Carlos Jaime‐Pérez, Mario Cesar Salinas-Carmona, Sandra Nora González Díaz, Ángeles Castro-Corona, Raúl Cavazos-González, Humberto Treviño-Villarreal, Alberto Carlos Heredia-Salazar, David Gómez‐Almaguer · 2017 · Revista Brasileira de Hematologia e Hemoterapia
  71. Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas
    Filipa Martins, Luís G. Gonçalves, Marta Pojo, Jacinta Serpa · 2020 · Biomolecules
  72. PEGylated E. coli asparaginase desensitization: an effective and feasible option for pediatric patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegaspargase in the absence of asparaginase Erwinia chrysanthemi availability
    Anupam R. Verma, Karin Chen, Cynthia Bender, Nathan Gorney, Whitney Leonard, Phillip Barnette · 2019 · Pediatric Hematology and Oncology
  73. Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines
    Wei Wen Chien, Céline Le Beux, Nicolas Rachinel, Michel Julien, Claire Lacroix, Soraya Allas, Pierre Sahakian, Aurélie Cornut-Thibaut, Loïc Lionnard, Jérôme Kucharczak et al. · 2015 · Scientific Reports
  74. Reprogramming neuroblastoma by diet-enhanced polyamine depletion
    Sarah Cherkaoui, Christina S. Turn, Yuan Yuan, Wenyun Lu, Lifeng Yang, Matthew J. McBride, Caroline Eigenmann, George Edward Allen, Olesya O. Panasenko, Lu Zhang et al. · 2025 · Nature
  75. Validation of a 30-year-old process for the manufacture of l-asparaginase from Erwinia chrysanthemi
    David P. Gervais, Nigel Allison, Alan Jennings, Shane Jones, Trevor S. Marks · 2012 · Bioprocess and Biosystems Engineering
  76. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia
    Vladan Rajić, Maruša Debeljak, Katja Goričar, Janez Jazbec · 2015 · Leukemia & lymphoma/Leukemia and lymphoma
  77. The role of autophagy in asparaginase-induced immune suppression of macrophages
    Ping Song, Ziyu Wang, Xuyao Zhang, Jiajun Fan, Yubin Li, Qicheng Chen, Shaofei Wang, Peipei Liu, Jingyun Luan, Li Ye et al. · 2017 · Cell Death and Disease
  78. Genomics-guided pre-clinical development of cancer therapies
    Hayley E. Francies, Ultan McDermott, Mathew J. Garnett · 2020 · Nature Cancer
  79. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia
    Louise Tram Henriksen, Jacob Nersting, Raheel Altaf Raja, Thomas Leth Frandsen, Steen Rosthøj, Henrik Daa Schrøder, Birgitte Klug Albertsen, the Nordic Society of Paediatric Haematology and Oncology (NOPHO) group · 2014 · British Journal of Haematology
  80. The cell-free system: A new apparatus for affordable, sensitive, and portable healthcare
    Caroline E. Copeland, Adam Langlois, Jeehye Kim, Yong‐Chan Kwon · 2021 · Biochemical Engineering Journal
  81. Asparagine, colorectal cancer, and the role of sex, genes, microbes, and diet: A narrative review
    Xinyi Shen, Abhishek Jain, Oladimeji B. Aladelokun, Hong Yuan Yan, Austin Gilbride, Leah M. Ferrucci, Lingeng Lu, Sajid Ali Khan, Caroline Helen Johnson · 2022 · Frontiers in Molecular Biosciences
  82. A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora
    Lisandra Herrera Belén, Jorge Félix Beltrán Lissabet, Carlota de Oliveira Rangel‐Yagui, Brian R. Effer, Gisele Monteiro, Adalberto Pessoa, Jorge G. Farías · 2019 · Biologicals
  83. Update on the Use of L-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia
    Augusto Faria Andrade, Kleiton Silva Borges, Vanessa S. Silveira · 2014 · Clinical Medicine Insights Oncology
  84. Reactions related to asparaginase infusion in a 10-year retrospective cohort
    Amanda Cabral dos Santos, Marcelo Gerardin Poirot Land, Nathalia Peroni da Silva, Kelly Oliveira Santos, Elisângela da Costa Lima · 2017 · Revista Brasileira de Hematologia e Hemoterapia
  85. Optimization of aqueous two-phase micellar system for partial purification of L-asparaginase from Penicillium sp. grown in wheat bran as agro-industrial residue
    Samuel Leite Cardoso, Marcela Medeiros de Freitas, Paula Monteiro Souza, Maurício Homem-de-Mello, Dâmaris Silveira, Yris Maria Fonseca-Bazzo, Edivaldo Ximenes Ferreira Filho, Adalberto Pessoa, Pérola Oliveira Magalhães · 2020 · Brazilian Journal of Microbiology
  86. Response surface methodological optimization of l-asparaginase production from the medicinal plant endophyte Acinetobacter baumannii ZAS1
    K.N. Abhini, Akhila B Rajan, Karattuthodi Fathimathu Zuhara, Denoj Sebastian · 2022 · Journal of Genetic Engineering and Biotechnology
  87. Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase
    Wei Wen Chien, Soraya Allas, Nicolas Rachinel, Pierre Sahakian, Michel Julien, Céline Le Beux, Claire Lacroix, Thierry Abribat, Gilles Salles · 2014 · Investigational New Drugs
  88. Recombinant TAT-gelonin fusion toxin: Synthesis and characterization of heparin/protamine-regulated cell transduction
    Meong Cheol Shin, Jingwen Zhao, Jian Zhang, Yongzhuo Huang, Huining He, Mei Wang, Kyoung Ah Min, Victor Chi-Min Yang · 2014 · Journal of Biomedical Materials Research Part A
  89. Components of cancer metabolism and therapeutic interventions
    John Singleterry, Annapoorna Sreedhar, Yunfeng Zhao · 2014 · Mitochondrion
  90. Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation
    Duccio Maria Cordelli, Riccardo Masetti, Daniele Zama, Francesco Toni, Ilaria Castelli, Emilia Ricci, Emilio Franzonı, Andrea Pession · 2017 · Frontiers in Pediatrics
  91. Overexpression of (His) 6 -tagged human arginase I in Saccharomyces cerevisiae and enzyme purification using metal affinity chromatography
    Andriy E. Zakalskiy, Oksana M. Zakalska, Yuriy Rzhepetskyy, Natalia Potocka, Oleh V. Stasyk, Daniel Horák, Mykhailo V. Gonchar · 2011 · Protein Expression and Purification
  92. The Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia
    Joshua Lukenbill, Anjali S. Advani · 2013 · Current Hematologic Malignancy Reports
  93. Overexpression of Asparagine Synthetase and Matrix Metalloproteinase 19 Confers Cisplatin Sensitivity in Nasopharyngeal Carcinoma Cells
    Ranyi Liu, Zizheng Dong, Jianguo Liu, Ling Zhou, Wenlin Huang, Sok Kean Khoo, Zhongfa Zhang, David Petillo, Bin Tean Teh, Chao-Nan Qian et al. · 2013 · Molecular Cancer Therapeutics
  94. Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951
    Veerle Mondelaers, Stefan Suciu, Barbara De Moerloose, Alina Ferster, Françoise Mazingue, Geneviève Plat, Karima Yakouben, Anne Uyttebroeck, Patrick Lutz, Vítor Costa et al. · 2017 · Haematologica
  95. Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients
    Michael Rytting · 2012 · Blood and Lymphatic Cancer Targets and Therapy
  96. Glutaminase-free L-asparaginase production byLeucosporidium muscorumisolated from Antarctic marine-sediment
    Rominne Karla Barros Freire, Carlos Miguel Nóbrega Mendonça, Rafael Bertelli Ferraro, Ignacio Sánchez‐Moguel, Aldo Tonso, Felipe Rebello Lourenço, João H. P. M. Santos, Lara Durães Sette, Adalberto Pessoa · 2020 · Preparative Biochemistry & Biotechnology
  97. Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment
    Cristina Díaz-Barriga, Francisca Villanueva‐Flores, Katrin Quester, Andrés Zárate‐Romero, Ruben Dario Cadena-Nava, Alejandro Huerta Saquero · 2021 · Pharmaceutics
  98. Yarrowia lipolytica in Biotechnological Applications
    Farshad Darvishi · 2014 · SpringerBriefs in microbiology
  99. Studies on Deimmunization of Antileukaemic L-Asparaginase to have Reduced Clinical Immunogenicity- An in silico Approach
    L. N. Ramya, Krishna Kanth Pulicherla · 2015 · Pathology & Oncology Research
  100. L-Carnitine Ameliorates L-Asparaginase-Induced Acute Liver Toxicity in Steatotic Rat Livers
    Anne Roesmann, Mamdouh Afify, Jens Panse, Albrecht Eisert, Julia Steitz, Rene Hany Tolba · 2013 · Chemotherapy